Download PDF
Thromb Haemost 1967; 18(03/04): 475-486
DOI: 10.1055/s-0038-1655057
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Formation and Properties of Fibrin Clots Resulting from Staphylocoagulase (SC) Action

M Kopeć
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
,
Z Węgrzynowicz
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
,
A. Z Budzyński
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
,
J Jeljaszewicz
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
,
Z. S Latallo
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
,
B Lipiński
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
,
E Kowalski
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw, and the Department of Bacteriology, Institute of Hygiene, Warsaw
› Author Affiliations
Further Information

Publication History

Publication Date:
19 September 2018 (online)

Also available at
    Permissions and Reprints

Summary

Some properties of the fibrin clots formed under the influence of staphylocoagulase (SC) and thrombin were compared.

1. Mechanical properties of SC-induced clots were found to be different from thrombin-induced clots. Maximal amplitude in TEG was significantly smaller in the case of SC.

2. In the system containing all other necessary components for fibrin stabilization, SC in contrasts to thrombin did not produce stabilized clots. It was shown that this was due to the lack of FSF activation by SC. SC induced fibrin was easily stabilized by the addition of FSF activated by thrombin. No difference in sialic acid content has been found when SC and thrombin induced fibrins were compared.

3. Neither clotting nor esterase activity of SC were inhibited by heparin and hirudin.

4. Fibrinogen degradation products (FDP) inhibit clotting activity of SC. Both early and late FDP seem to affect this activity in a similar degree, whereas early FDP show much more pronounced effect in the case of thrombin induced clotting.

5. The SC-clots are much more resistant to plasmin action, although SC itself does not inhibit plasmin caseinolytic activity.

6. The significance of these findings is discussed.

 

  • References

  • 1 Aminoff D. Methods for the quantitative estimation of N-acetyloneuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81: 384 1961;
    CrossrefPubMedSearch in Google Scholar
  • 2 Budzyński A. Z, Latallo Z. S, Kowalski B. ELipiński. The effect of pH on interaction of fibrinogen degradation products (FDP) with the fibrinogen-fibrin conversion. Bull. Acad. pol. Sci. 11: 477 1963;
    PubMedSearch in Google Scholar
  • 3 Drummond M. C, Tager M. Fibrinogen clotting and fibrinopeptite formation by staphylocoagulase and the coagulase reacting factor. J. Bacteriol. 85: 628 1963;
    PubMedSearch in Google Scholar
  • 4 Duthie E. S, Haughton G. Purification of free staphylococcal coagulase. Biochem. J. 70: 125 1958;
    CrossrefPubMedSearch in Google Scholar
  • 5 Haughton G, Duthie E. S. The activation of staphylococcal free coagulase by plasma constituents and hydrolysis of N-toluene-sulphonyl-1-arginine methyl ester (TAMe) by activated coagulase. Biochem. J. 71: 348 1959;
    CrossrefPubMedSearch in Google Scholar
  • 6 Jeliaszewicz J, Niewiarowski S, Poplawski S, Prokopowicz J, Worowski K. Intravascular coagulation and fibrinolysis by staphylocoagulase. Comparison with thrombin. Thrombos. Diathes. haemorrh. (Stuttg). 13: 457 1965;
    PubMedSearch in Google Scholar
  • 7 Kekwick R. A, Mackay M. E, Nance M. H, Record B. R. The purification of human fibrinogen. Biochem. J. 60: 671 1955;
    PubMedSearch in Google Scholar
  • 8 Kopeć M, Budzyński A. Z, Stachurska J, Węgrzynowicz Z, Kowalski E. Studies on the mechanism of interference by fibrinogen degradation products (FDP) with platelet function. Role of the fibrinogen in the platelet atmosphere. Thrombos. Diathes. haemorrh. (Stuttg). 15: 476 1966;
    PubMedSearch in Google Scholar
  • 9 Kowalski E, Budzyński A. Z, Kopeć M, Latallo Z. S, Lipiński B, Węgrzynowicz Z. Circulating fibrinogen degradation products (FDP) in dog blood after intravenous thrombin infusion. Thrombos. Diathes. haemorrh. (Stuttg). 13: 12 1965;
    PubMedSearch in Google Scholar
  • 10 Laki K, Chandrasekhar N. Sialic acid in fibrinogen and “vulcanization” of the fibrin clot. Nature (Lond). 197: 1267 1960;
    PubMedSearch in Google Scholar
  • 11 Latallo Z. S, Budzyński A. Z, Lipiński B, Kowalski E. Inhibition of thrombin and fibrin polymerization, two activities derived from plasmin digested fibrinogen. Nature (Lond). 203: 1184 1964;
    CrossrefPubMedSearch in Google Scholar
  • 12 Lipiński B, Węgrzynowicz Z, Budzyński A. Z, Kopeć M, Latallo Z, Kowalski E. Soluble complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombos. Diathes. haemorrh. (Stuttg). 17: 65 1967;
    PubMedSearch in Google Scholar
  • 13 Loewy A. G, Veneziale G, Forman M. Purification of the factor involved in the formation of urea-insoluble fibrin. Biochim. biophys. Acta (Amst). 26: 670 1957;
    CrossrefPubMedSearch in Google Scholar
  • 14 Miale J. B. Relationship of coagulase-globulin to prothrombin. Proc. Soc. exp. Biol. (N. Y). 75: 432 1950;
    CrossrefPubMedSearch in Google Scholar
  • 15 Miale J. B. The role of coagulase-globulin in blood coagulation and its thromboplastic action. Amer. J. clin. Pathol. 22: 218 1952;
    PubMedSearch in Google Scholar
  • 16 Murray M, Gray Jr. L. A. The formation of fibrin variants. Exp. molecul. Pathol. 03: 287 1964;
    PubMedSearch in Google Scholar
  • 17 Rubinstein M. H. Studies on the mechanism of action of staphylocoagulase. Brit. J. Haemat. 04: 326 1958;
    CrossrefPubMedSearch in Google Scholar
  • 18 Soulier J. P. Properties of thrombin-coagulase (derived from staphylocoagulase). XIth Congress of International Society of Haematology. Abstracts of papers. Sydney 1966. 243.
    PubMed
  • 19 Soulier J. P. O. Prou: Staphylocoagulase and prothrombin. In: Diffuse intravascular clotting. 255 Schattauer; Stuttgart: 1966
    Search in Google Scholar
  • 20 Tager M. Problems in coagulation of plasma by staphylocoagulase. Ann. N.Y. Acad. Sci. 65: 109 1956;
    CrossrefPubMedSearch in Google Scholar
  • 21 Tager M. Studies on the nature and purification of the coagulase reacting factor and its relation to prothrombin. J. exp. Med. 104: 675 1956;
    CrossrefPubMedSearch in Google Scholar